LOWDEXA
Live / Applied — First extension granted (statement of use) (as of 04 Nov 2025)
What this means for you
Not registered yet, but its 01 Jul 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98627424
- Mark type
- Stylized text
- Filed
- 01 Jul 2024
- Published for opposition
- 11 Mar 2025
- Attorney of record
- David M. Sigmon
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, steroids in tablet form
Owner
- Pangea Pharmaceuticals, LLC, Brielle, NJ, US
- Pangea Pharmaceuticals, LLC, Brielle, NJ, US
Prosecution history
- 05 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Nov 2025 — SOU EXTENSION 1 GRANTED
- 04 Nov 2025 — SOU EXTENSION 1 FILED
- 04 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 06 May 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 11 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Mar 2025 — PUBLISHED FOR OPPOSITION
- 05 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Feb 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Jan 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Jan 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Jan 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 27 Dec 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 27 Dec 2024 — NON-FINAL ACTION E-MAILED
- 27 Dec 2024 — NON-FINAL ACTION WRITTEN